• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ElF5B as a prognostic biomarker and its correlation with infiltrating immune cells in liver cancer.

作者信息

Kim Tae-Young, Bae An-Na, Lee Jae-Ho

机构信息

Department of Anatomy, Keimyung University School of Medicine, Daegu, South Korea.

出版信息

Genes Genomics. 2025 Aug 25. doi: 10.1007/s13258-025-01671-6.

DOI:10.1007/s13258-025-01671-6
PMID:40853612
Abstract
摘要

相似文献

1
ElF5B as a prognostic biomarker and its correlation with infiltrating immune cells in liver cancer.ElF5B作为一种预后生物标志物及其与肝癌中浸润免疫细胞的相关性。
Genes Genomics. 2025 Aug 25. doi: 10.1007/s13258-025-01671-6.
2
Multi-omics analysis of zinc finger protein 683 as a prognostic biomarker for immune infiltration in clear cell renal cell carcinoma.锌指蛋白683作为透明细胞肾细胞癌免疫浸润预后生物标志物的多组学分析
BMC Cancer. 2025 Jul 29;25(1):1236. doi: 10.1186/s12885-025-14643-6.
3
ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.ZBED4：肝细胞癌的一种预后生物标志物和治疗靶点
J Hepatocell Carcinoma. 2025 Aug 21;12:1873-1892. doi: 10.2147/JHC.S546808. eCollection 2025.
4
TTC36 as a prognostic biomarker in nonmetastatic hepatocellular carcinoma: A TCGA-based cohort study.TTC36作为非转移性肝细胞癌的预后生物标志物：一项基于TCGA的队列研究。
Medicine (Baltimore). 2025 Jul 11;104(28):e43135. doi: 10.1097/MD.0000000000043135.
5
Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma.全癌系统分析确定NCOA4为一种免疫和预后生物标志物，并在肺腺癌中得到验证。
Discov Oncol. 2025 Jul 28;16(1):1422. doi: 10.1007/s12672-025-03064-3.
6
In-depth evaluation of XPR1 as a new prognostic indicator for endometrial cancer.对XPR1作为子宫内膜癌新预后指标的深入评估。
BMC Cancer. 2025 Sep 2;25(1):1411. doi: 10.1186/s12885-025-14818-1.
7
Comprehensive pan-cancer analysis reveals NTN1 as an immune infiltrate risk factor and its potential prognostic value in SKCM.全面的泛癌分析揭示NTN1作为一种免疫浸润风险因素及其在皮肤黑色素瘤中的潜在预后价值。
Sci Rep. 2025 Jan 25;15(1):3223. doi: 10.1038/s41598-025-85444-x.
8
VPS26A as a Prognostic Biomarker and Therapeutic Target in Liver Hepatocellular Carcinoma: Insights from Comprehensive Bioinformatics Analysis.VPS26A作为肝细胞癌的预后生物标志物和治疗靶点：综合生物信息学分析的见解
Medicina (Kaunas). 2025 Jul 16;61(7):1283. doi: 10.3390/medicina61071283.
9
G6PC1 expression as a prognostic biomarker associated with metabolic reprogramming and tumor microenvironment in hepatocellular carcinoma.G6PC1表达作为与肝细胞癌代谢重编程和肿瘤微环境相关的预后生物标志物。
Front Immunol. 2025 Aug 1;16:1623315. doi: 10.3389/fimmu.2025.1623315. eCollection 2025.
10
ALDOB is a prognostic biomarker and a potential immunotherapy target for clear cell renal cell carcinoma.醛缩酶B（ALDOB）是透明细胞肾细胞癌的一种预后生物标志物和潜在的免疫治疗靶点。
PeerJ. 2025 Aug 18;13:e19869. doi: 10.7717/peerj.19869. eCollection 2025.

本文引用的文献

1
Comminuted Paraspinal Rib Fractures with Resultant Impending Penetrating Aortic Injury Requiring Costovertebral Rib Fixation: A Case Report.伴有即将发生的穿透性主动脉损伤且需肋椎关节肋骨固定的粉碎性椎旁肋骨骨折：一例报告
Medicina (Kaunas). 2024 Dec 15;60(12):2063. doi: 10.3390/medicina60122063.
2
Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-Akt signaling pathway.环状 RNA ACVR2A 通过靶向 miR-511-5p 调控 PI3K-Akt 信号通路促进肝癌进展。
Mol Cancer. 2024 Aug 6;23(1):159. doi: 10.1186/s12943-024-02074-z.
3
Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers.
TRF1和TRF2表达在非小细胞肺癌中的不同作用
Onco Targets Ther. 2024 Jun 4;17:463-469. doi: 10.2147/OTT.S461430. eCollection 2024.
4
IGF2BP3-induced activation of EIF5B contributes to progression of hepatocellular carcinoma cells.IGF2BP3 诱导的 EIF5B 激活促进肝癌细胞的进展。
Oncol Res. 2023 Jan 5;30(2):77-87. doi: 10.32604/or.2022.026511. eCollection 2022.
5
Expression of Eukaryotic Translation Initiation Factors in the Urothelial Carcinoma of the Bladder.真核翻译起始因子在膀胱癌中的表达。
Anticancer Res. 2023 Apr;43(4):1437-1448. doi: 10.21873/anticanres.16292.
6
The new oncogene transmembrane protein 60 is a potential therapeutic target in glioma.新型癌基因跨膜蛋白60是胶质瘤的一个潜在治疗靶点。
Front Genet. 2023 Jan 20;13:1029270. doi: 10.3389/fgene.2022.1029270. eCollection 2022.
7
P14.5 functions to inhibit cell migration and can be used as a prognostic marker in hepatocellular carcinoma.P14.5具有抑制细胞迁移的功能，可作为肝细胞癌的预后标志物。
Genes Genomics. 2023 Jan;45(1):83-91. doi: 10.1007/s13258-022-01331-z. Epub 2022 Nov 24.
8
Wnt/β-catenin targeting in liver carcinoma through nanotechnology-based drug repurposing: A review.基于纳米技术药物再利用的肝癌 Wnt/β-catenin 靶向治疗：综述。
Biomed Pharmacother. 2022 Nov;155:113713. doi: 10.1016/j.biopha.2022.113713. Epub 2022 Sep 19.
9
eIF5B regulates the expression of PD-L1 in prostate cancer cells by interacting with Wig1.真核生物翻译起始因子5B（eIF5B）通过与Wig1相互作用来调节前列腺癌细胞中程序性死亡受体配体1（PD-L1）的表达。
BMC Cancer. 2021 Sep 15;21(1):1022. doi: 10.1186/s12885-021-08749-w.
10
Established and Emerging Regulatory Roles of Eukaryotic Translation Initiation Factor 5B (eIF5B).真核生物翻译起始因子5B（eIF5B）已确立的和新出现的调控作用
Front Genet. 2021 Aug 27;12:737433. doi: 10.3389/fgene.2021.737433. eCollection 2021.